Hemophilia A: all 885 studies
Page 7 of 9. Open to participants first (139), then studies with results posted, then the rest; newest registration first within each.
- Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe HemophiliaCompletedNCT03185897
- Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A PatientsCompletedNCT03179748
- Hemophilia Mobile App Usability PilotStatus unknownNCT03168685Not applicable
- Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet TherapiesCompletedNCT03157154
- An Expanded Access Program of Emicizumab in Participants With Hemophilia A With InhibitorsApproved for marketingNCT03154437
- DDAVP vs. Exercise in Patients With Mild Hemophilia AStatus unknownNCT03136003Phase 4
- A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia BCompletedNCT03075670Phase 1
- A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or BCompletedNCT03055611
- Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.CompletedNCT03054662Not applicable
- Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator InterviewsCompletedNCT03054389
- Fascial Therapy in Elbow Hemophilic ArthropathyCompletedNCT03009591Not applicable
- Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®CompletedNCT03006965
- Individualizing Hemophilia Bypassing Agent Therapy Utilizing ThromboelastographyWithdrawnNCT03002480Not applicable
- Gene Therapy for Haemophilia A.Active, not recruitingNCT03001830Phase 1/2
- A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A ChildrenStatus unknownNCT02999308Phase 4
- Key Aspects of Medical Practice in Patients With Haemophilia AWithdrawnNCT02996942
- Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia ACompletedNCT02994407Phase 1
- Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor ProductsCompletedNCT02976753
- Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia BCompletedNCT02971969
- Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia ACompletedNCT02971930
- Drug Use Investigation of Kovaltry in Hemophilia A PatientsCompletedNCT02941783
- Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia ACompletedNCT02941354Phase 1
- UK - EHL Outcomes RegistryStatus unknownNCT02938156
- Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia AStatus unknownNCT02930317Phase 3
- Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South KoreaCompletedNCT02922231
- Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia AStatus unknownNCT02921945Phase 3
- A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia ACompletedNCT02920398Phase 1
- A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult MaleCompletedNCT02919800Phase 1
- Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation CapacityCompletedNCT02911233
- Outcomes of Prophylaxis and On-demand Treatment for Severe Hemophiliacs and Collection of Baseline Data in Hemophiliacs in TaiwanStatus unknownNCT02908243
- Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia AStatus unknownNCT02888223Phase 1
- Effectiveness of Psychological Interventions in HaemophiliaCompletedNCT02870452Not applicable
- National Survey of People With Haemophilia in PortugalCompletedNCT02870114
- Determinants and Consequences of the Transition to Adulthood Among Adolescents With HaemophiliaCompletedNCT02866526
- Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study.CompletedNCT02851082Not applicable
- Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine ProphylaxisCompletedNCT02830477
- Educational Physiotherapy in HaemophiliaCompletedNCT02825706Not applicable
- Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of AnkleCompletedNCT02825667Not applicable
- The Hemophilia Ultrasound ProjectTerminatedNCT02807753
- Factor Product Utilization and Health Outcomes in Patients With HemophiliaCompletedNCT02796222
- TGA (Thrombin Generation Assay) and Prophylaxis in HaemophiliaStatus unknownNCT02781766Not applicable
- A Progressive Resistance Training Program in Patients With HaemophiliaCompletedNCT02781233Not applicable
- World Bleeding Disorders Registry Pilot StudyCompletedNCT02776826
- Evaluation of a Simple Pharmacokinetic Tool (myPKFiT™) to Guide Personalized Factor VIII Dosing in Patients With HemophiliaStatus unknownNCT02750085
- Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric PatientsCompletedNCT02727647Phase 4
- Improved Factor VIII Inhibitor EvaluationWithdrawnNCT02726139
- Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine ProphylaxisWithdrawnNCT02718677
- Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia ACompletedNCT02697370Phase 4
- GAS-Hem Feasibility StudyCompletedNCT02674997
- Ultrasonography in Hemophilic Joint Disease and Serum MarkersCompletedNCT02634918
- Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia ACompletedNCT02634723
- PK Driven Prophylaxis for Hemophilia ATerminatedNCT02634424Not applicable
- Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A PatientsStatus unknownNCT02622646
- Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia ACompletedNCT02610127
- Risk Models to Optimise Prophylaxis Schedules in Children With HaemophiliaCompletedNCT02585635
- Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With HemophiliaStatus unknownNCT02582450
- Individualizing Hemophilia Prophylaxis Using ThromboelastographyCompletedNCT02582060Not applicable
- Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."CompletedNCT02581969
- Effectiveness of the uPatient Platform in Prophylactic Treatment in HemophiliaStatus unknownNCT02581735
- A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without InhibitorsCompletedNCT02571569Phase 1
- Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)CompletedNCT02568202
- Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With InhibitorsStatus unknownNCT02554526
- ATHN 2: Factor Switching StudyCompletedNCT02546622
- Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B PatientsCompletedNCT02540187
- National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia ACompletedNCT02528968Not applicable
- Validation of Questionnaires HAL and HEPStatus unknownNCT02512211
- Characterization of Laboratory Response to DDAVP in Adult Hemophilia A CarriersCompletedNCT02506023Phase 1
- Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A SubjectsCompletedNCT02490787Phase 1
- Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With InhibitorsTerminatedNCT02484638Phase 2/3
- Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and AdvateCompletedNCT02483208Phase 1
- Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A PatientsStatus unknownNCT02479087Phase 4
- A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care TreatmentCompletedNCT02476942
- Myofascial Therapy in Patients With Hemophilic ArthropathyStatus unknownNCT02433782Not applicable
- A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or BCompletedNCT02418793Phase 1
- A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and VenipunctureTerminatedNCT02402829
- Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its TreatmentCompletedNCT02396862
- Fc factOrs and Real-World hemophiliA Patient-ReporteD OutcomesTerminatedNCT02392156
- The Effect of Functional Activities and Balance Ability With Taping in Subjects of HemophiliaStatus unknownNCT02389205Not applicable
- Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia ACompletedNCT02362581Not applicable
- Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding DisordersStatus unknownNCT02324517
- 2-cohort Study of Adult Patients With Severe Hemophilia A in GreeceCompletedNCT02319070
- Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis RegimensStatus unknownNCT02314325Phase 4
- Thrombin Generation Numerical Models Validation in Haemophilic CaseCompletedNCT02300519
- Colorado Adult Joint Assessment Scale (CAJAS) ValidationCompletedNCT02284789Not applicable
- Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia AStatus unknownNCT02282410Not applicable
- Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia AStatus unknownNCT02280265Not applicable
- Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)CompletedNCT02279199
- A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 YearsCompletedNCT02263469Phase 3
- A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia BCompletedNCT02263456Phase 3
- Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular ProphylaxisCompletedNCT02263066
- Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With Haemophilia A by Means of AccelerometryCompletedNCT02253693
- An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing SurgeryCompletedNCT02250573Phase 3
- A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.CompletedNCT02250560Phase 3
- An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.CompletedNCT02250482Phase 3
- A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.CompletedNCT02246894Phase 3
- A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.CompletedNCT02246881Phase 3
- An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.CompletedNCT02246868Phase 3
- To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily LivesCompletedNCT02241694
- An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B PatientsCompletedNCT02231944Phase 3
- Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.CompletedNCT02229331